Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | CHRO | Promissory Note | Feb 15, 2024 | Common Stock | $175K | Direct | F1 | |||||||
holding | CHRO | Stock Options | Feb 15, 2024 | Common Stock | 33.3K | $22.68 | Direct | F2 | ||||||
holding | CHRO | Stock Options | Feb 15, 2024 | Common Stock | 22.2K | $22.68 | Direct | F3 |
Id | Content |
---|---|
F1 | The Reporting Person holds a promissory note with a face amount of $175,000 and purchase price of $100,000, which provides the Reporting Person the right but not the obligation, to purchase securities offered in the Issuer's initial public offering by presenting the promissory note in whole or in part to purchase such securities as legal tender therefor on a dollar-for-dollar basis based upon the offering price of such securities to the public. The promissory note bears no interest except in the case of certain events of default. |
F2 | On January 10, 2023, the Reporting Person was granted stock options to purchase 33,334 shares of common stock at an exercise price of $22.68 per share. 3,334 shares of such options became exercisable on April 10, 2023, 3,334 shares of such options became exercisable on July 10, 2023, 3,334 shares of such options became exercisable on October 10, 2023, 3,334 shares of such options became exercisable on January 10, 2024, 3,334 shares of such options will become exercisable on April 10, 2024 and the remaining 16,664 shares of such options shall become exercisable in equal installments on a quarterly basis, subject to the Reporting Person's continued service to Issuer. The final installment shall become exercisable on July 10, 2025, subject to the Reporting Person's continued service to Issuer. |
F3 | On January 10, 2023, the Reporting Person was granted stock options to purchase 22,223 shares of common stock at an exercise price of $22.68 per share which shall become exercisable upon Issuer's establishment of a second clinical program, subject to the Reporting Person's continued service to Issuer. |
Exhibit 24 - Power of Attorney